A detailed history of Wells Fargo & Company transactions in Psychemedics Corp stock. As of the latest transaction made, Wells Fargo & Company holds 1 shares of PMD stock, worth $2. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 1 -0.0%
Holding current value
$2
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$2.25 - $2.88 $83 - $106
-37 Reduced 97.37%
1 $0
Q1 2024

May 10, 2024

BUY
$2.92 - $3.79 $2 - $3
1 Added 2.7%
38 $0
Q4 2023

Feb 09, 2024

BUY
$2.06 - $3.69 $4 - $7
2 Added 5.71%
37 $0
Q3 2023

Nov 13, 2023

BUY
$3.66 - $5.05 $3 - $5
1 Added 2.94%
35 $0
Q2 2023

Aug 15, 2023

BUY
$4.55 - $5.6 $9 - $11
2 Added 6.25%
34 $0
Q4 2022

Feb 13, 2023

BUY
$4.9 - $6.7 $9 - $13
2 Added 6.67%
32 $0
Q3 2022

Nov 14, 2022

SELL
$6.08 - $6.84 $18 - $20
-3 Reduced 9.09%
30 $0
Q2 2022

Aug 12, 2022

BUY
$6.1 - $7.04 $18 - $21
3 Added 10.0%
33 $0
Q4 2021

Feb 14, 2022

SELL
$6.86 - $8.79 $1,763 - $2,259
-257 Reduced 89.55%
30 $0
Q3 2021

Nov 15, 2021

BUY
$6.31 - $8.4 $1,596 - $2,125
253 Added 744.12%
287 $2,000
Q1 2021

May 13, 2021

SELL
$4.95 - $7.7 $11,870 - $18,464
-2,398 Reduced 98.6%
34 $0
Q4 2020

Feb 09, 2021

SELL
$3.67 - $5.1 $27,789 - $38,617
-7,572 Reduced 75.69%
2,432 $13,000
Q3 2020

Nov 05, 2020

SELL
$4.33 - $6.05 $18,662 - $26,075
-4,310 Reduced 30.11%
10,004 $44,000
Q2 2020

Aug 13, 2020

SELL
$4.9 - $6.14 $11,911 - $14,926
-2,431 Reduced 14.52%
14,314 $79,000
Q1 2020

May 14, 2020

BUY
$4.63 - $10.62 $77,529 - $177,831
16,745 New
16,745 $101,000

Others Institutions Holding PMD

About PSYCHEMEDICS CORP


  • Ticker PMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 5,626,200
  • Market Cap $13.2M
  • Description
  • Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, ...
More about PMD
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.